Gunjan Bagla

Jun 20, 2024 | biosimilardevelopment.com | Susan Shockey |Tim Sandle |Gunjan Bagla

Get more biosimilar development insight with our FREE newsletter Newsletter | June 20, 2024 Register by 17 July to Save up to 20% The PDA/FDA Joint Regulatory Conference 2024, the only FDA co-sponsored pharmaceutical CGMP conference, is taking place 9 to 11 September in Washington, D.C. Now in its 33rd year, the conference will offer a comprehensive agenda with substantive technical sessions and practical case studies that provide insight into the effective application of Current Good...

Jun 14, 2024 | pharmaceuticalonline.com | Gunjan Bagla |Anoop Gupta |Tony Paine

With over 35 years' experience in the medtech, diagnostics, and pharmaceutical markets, SMC Ltd. provides in-house engineering, injection molding, assembly, fill finish, device manufacturing, packaging services, and can manage sterilization. Our customers rely on us for speed-to-market and our program management process is a key to well managed projects. With inhouse global supply chain expertise, we help customers reduce risk while maintaining tight timeframes.

Jun 11, 2024 | bioprocessonline.com | Gunjan Bagla |Mel Palmer |Lars Petersen |FUJIFILM Diosynth Biotechnologies

Webinar: Navigating your Holistic Approach to Container Closure Integrity for Biologic Drug ProductsJoin us on June 12th to see the benefit of a comprehensive approach to CCI tailored for several biologic drug products -mAbs and complex modalities such as fusion proteins or bioconjugates as well as learn the regulatory expectations and industry best practices on CCI! We’ll discuss timely initiate activities of more complex cases such as combinations products. Click here to learn more.

Jun 3, 2024 | outsourcedpharma.com | Gunjan Bagla |Louis Garguilo

Guest Column | June 3, 2024 By Gunjan Bagla, Amritt Inc. Please note: This is not a legal document, although I have included input from attorneys based in the USA and in India. The objective is to give American life sciences companies a lens through which to view any business dealing with India.

Sep 29, 2023 | meddeviceonline.com | Gunjan Bagla

By Gunjan Bagla, Amritt Inc. While India’s medical device industry has grown at a steady 14%–15% annually for most of the last decade, it only accounts for 1.5% of the global market. Now the country’s federal government has created a far-reaching policy with the goal of spiking growth to over 20% for the next decade.